BRUSSELS — On Oct. 16, Mars announced changes to the leadership of two divisions within its pet care business. Nefertiti Greene, current president of Mars Science & Diagnostics, will move to the role of global president for Mars Veterinary Health in December. With this change, Katie Devine will be joining the company as the new global president of Mars Science & Diagnostics on Oct. 21. 

Both Greene and Devine will report to Loïc Moutault, president of Mars Petcare.

Greene joined Mars in 2022 to lead the newly created Science & Diagnostics division. During the last two years, she has led the growth of the business, building a full diagnostics portfolio. Greene has extensive experience in services and healthcare, with nearly 30 years at companies like Johnson & Johnson (J&J), Bayer and Forest Laboratories (now Allergan) in several roles across both the human pharmaceutical and medical technology sectors.

“I’m delighted that Nef will step up to lead our Veterinary Health business, working with 70,000 passionate, pet-loving associates,” Moutault said. “She is a hugely talented leader with decades of complementary experience across health and services. I’m confident under Nef’s leadership we will harness the knowledge, talent and resources across our organization to support the veterinary profession and deliver world leading care for pets.”

Katie Devine, global president of Mars Science & Diagnostics

Katie Devine, global president of Mars Science & Diagnostics.

| Source: Mars Petcare

Devine joins Mars from J&J where she most recently served as president of US General Medicines, Canada & Puerto Rico, a combined business of nearly $6.5 billion in revenue and more than 2,000 employees. During her time at J&J she worked in Cardiovascular Health, Infectious Disease, Pain Relief, Allergy, Digestive Health, Smoking Cessation and Skin Health. Her career has spanned more than 25 years in consumer health and pharmaceutical businesses across operations, supply chain, marketing, sales and general management.

“We are delighted to welcome Katie to Mars — and are excited for the next phase of growth for the Science & Diagnostics business,” Moutault said. “Diagnostics in animal health is so important, because pets can’t talk — so innovative diagnostics capabilities enable veterinary professionals to better understand and respond to companion animal health needs. I’m confident Katie is the right leader to continue the great progress of the last two years.”

Read more about personnel changes throughout the industry.